Vice President, Project Management
United States of America
Prior to joining Intensity Therapeutics, Caroline Hill spent 13 years at BMS in R&D operations, with her most current role as Head Regional R&D operations and Schedule management, having responsibility across the portfolio covering Discovery to life cycle management. Prior to this role, Caroline was responsible for the management of the Specialty portfolio including CV, IMS, Virology, Fibrotic Disease and Genetically Defined Diseases and has been involved with managing multiple licensing, partnering and acquisition opportunities. Prior to joining BMS, Caroline spent 8 years at Vion Pharmaceuticals, starting as a research scientist in Microbiology and ending her tenure as the Director of Quality Control/ Analytical and Bio-Analytical Development and Manufacturing where she was responsible for all pre-clinical and clinical analytical development for biologics and small molecules as well as analysis of clinical samples and all operational logistics to support clinical PK/PD.
microbiology,Therapeutic Radiology and Genetics investigating the role of DNA polymerase in base excision repair (BER) and the role of BER in carcinogenesis.